ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Working Group Lists Research Needed

July 1, 1988

O’Leary Leads RPCI’s OR;

February 8, 2002

John Niederhuber Named Acting NCI Director.

June 2, 2006

New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology

November 22, 1996

JRB Wins $3.6 Million Support contract

November 29, 1974

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

November 14, 2003